Report of Foreign Issuer (6-k)
June 06 2017 - 5:03PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
EXHIBIT INDEX
|
|
Exhibit
|
Description of Exhibit
|
|
|
|
Management Discussion and Analysis of the Financial Situation and Operating Results – Thirteen-Month and One-Month Periods Ended March 31, 2017, Twelve-Month Period ended February 28, 2017 and Years Ended February 29, 2016 and February 28, 2015
|
|
|
|
Financial Statements for the Thirteen-Month and One-Month Periods Ended March 31, 2017, Twelve-Month Period ended February 28, 2017 and Years Ended February 29, 2016 and February 28, 2015
|
|
|
99.3
|
Consent of KPMG LLP
|
Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
From Apr 2023 to Apr 2024